29.06.2017 • News

Brenntag to Buy Chinese Distributor Wellstar

(c) Brenntag
(c) Brenntag

In a two-step transaction, internationally active German chemical distributor Brenntag plans to acquire all of the shares in specialty chemical distributor Wellstar Enterprises (Hong Kong), along with its three Chinese subsidiaries, known jointly as the Wellstar Group. Financial terms have not been disclosed.

Brenntag said it will gain the majority stake of 51% in the Chinese company “over the course of the next few weeks” and take the remaining 49% by 2021. In the interim, the business will be operated as a joint venture.

Headquartered in Hong Kong and with subsidiaries in Shenzhen, Guangzhou and Shanghai, Wellstar Group distributes high performance pigments, effect pigments, resins and kaolin used in a broad variety of industries including coatings, inks, plastic and cosmetics. It also offers value-added services through an application lab for coatings.

In 2016, the company reported total sales of around €27.6 million, with most of its business in China.

Anthony Gerace, managing director Mergers & Acquisitions at Brenntag Group, said the distribution giant sees the joint venture as well positioned to grow on the back of favorable market trends, such as the growth in automotive industry in China.

Pointing to “synergy potential” with Brenntag China's existing customer base, Gerace said, the acquisition will allow it strengthen its relationship with a strategic key supplier. Henri Nejade, CEO Brenntag Asia Pacific, added that the purchase offers a chance to build up a specialty chemical division for industry segments such as coatings and personal care.

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.